Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (Miniantibody) (MNAB-164)

Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (Miniantibody) is a fusion protein of two scFv fragments combined with distinct specificity. One scFv of an anti-gp40 antibody variable domain is linked to another scFv of an anti-TFRC antibody variable domain by a flexible hinge region. This BsAb format has the decreased size and better penetration than conventional IgGs in the clinical diagnostics and potentially therapy. This BsAb can bind two tumor antigens simultaneously. It is designed for the research of Colon cancer; Ovarian cancer therapy.

Datasheet INQUIRY

Specifications

Targets

gp40 & TFRC

Type

Miniantibody

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Colon cancer; Ovarian cancer

Targets

Target 1

gp40

Alternative Names

gp40; glycoprotein 40; adenocarcinoma-associated antigen

Target 2

TFRC

Gene ID

7037

UniProt ID

P02786

Alternative Names

TFRC; transferrin receptor; T9; TR; TFR; p90; CD71; TFR1; TRFR; transferrin receptor protein 1; transferrin receptor (p90, CD71); IMD46

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (Miniantibody) (MNAB-164). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (Miniantibody) (CAT#: MNAB-164)

Specifications

Targets

Customer Reviews and Q&As